Johnson & Johnson reports fiscal Q1 2026 results: revenue $24.06B, up 10% from a year earlier

Johnson & Johnson filed a Form 8-K with the SEC on Apr 14, 2026, 7:35 AM ET, reporting an event dated Apr 14, 2026. It covers Item 2.02 (Results of Operations and Financial Condition); Item 8.01 (Other Events); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q1 2026 (quarter ended Mar 29, 2026); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $24.06B (+9.9% from $21.89B a year earlier)
• Net income: $5.24B (−52.4% from $11.00B a year earlier)
• Diluted EPS: $2.14 (−52.9% from $4.54 a year earlier)
• Form 8-K accepted by EDGAR Apr 14, 2026, 7:35 AM ET
• Accession number 0000200406-26-000076

SEC filing 8-K · accession 0000200406-26-000076 · sec.gov ↗